Core Insights - MetLife, Inc. has a market capitalization of $51.4 billion and operates in six business segments, providing a wide range of financial services including insurance, annuities, employee benefits, and asset management solutions [1] Stock Performance - Over the past 52 weeks, MetLife's stock has decreased by 7.8%, underperforming the S&P 500 Index, which has increased nearly 14% [2] - Year-to-date, MetLife shares are down 1.2%, contrasting with a slight rise in the S&P 500 [2] - The stock has also lagged behind the State Street Financial Select Sector SPDR ETF, which has returned 5.5% over the same period [3] Financial Results - MetLife reported strong Q4 2025 results, with net investment income rising to $5.92 billion, driven by favorable market conditions following U.S. Federal Reserve rate cuts [5] - Adjusted premiums, fees, and other revenues surged by 29% to $18.61 billion, while adjusted EPS increased by 19% to $2.49 [5] - The company benefited from strong volume growth, improved expense margins, disciplined premium pricing, and solid consumer spending trends [5] Future Earnings Expectations - For the fiscal year ending December 2026, analysts project MetLife's adjusted EPS to grow by 10.9% year-over-year to $9.86 [6] - The company's earnings surprise history is mixed, with two beats and two misses in the last four quarters [6] - Among 19 analysts covering the stock, the consensus rating is a "Moderate Buy," with 12 "Strong Buy" ratings and seven "Holds" [6] Analyst Ratings and Price Targets - Wells Fargo analyst Elyse Greenspan raised MetLife's price target to $97, maintaining an "Overweight" rating [8] - The mean price target of $92.94 suggests a premium of 19.1% to current levels, while the highest price target of $102 implies a potential upside of 30.8% [8]